查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2093181

胃食道逆流症治療醫療設備市場－2026-2032年全球市場預測

Gastroesophageal Reflux Disease Devices Market - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，用於治療胃食道逆流的醫療設備市場將成長至 20.8 億美元，複合年成長率為 8.81%。

主要市場統計數據
基準年 2025 11.5億美元
預計年份：2026年 12.2億美元
預測年份 2032 20.8億美元
複合年成長率 (%) 8.81%

胃食道逆流病醫療設備市場簡介

胃食道逆流症 (GERD) 仍然是全球最常見的慢性消化系統疾病之一，因此，GERD醫療設備在診斷、症狀管理和治療中發揮著日益重要的作用。這類器械包括門診 pH 值和電阻監測系統、食道測壓平台、內視鏡治療設備、射頻消融系統、植入式抗逆流技術以及用於胃底折疊和括約肌增強術的腹腔鏡手術器械。這種需求源自於臨床上評估逆流程度、識別非糜爛性逆流、確定難治性病例的治療策略以及減少特定患者長期依賴藥物治療的需求。此外，醫療系統越來越重視在進行侵入性操作前進行客觀檢測，這進一步強化了先進診斷設備的作用。同時，患者對微創手術、更短恢復時間和持續症狀管理的偏好也在改變醫療器材的選擇模式。監管審查、保險報銷差異、醫生培訓要求以及證據收集標準等因素持續影響著醫療器材的商業化進程。因此，目前胃食道逆流（GERD）醫療設備的發展趨勢是從基於症狀的治療轉向精準診斷、病患分層和標靶手術治療。

胃食道逆流病醫療設備引進方面的變革性變化

胃食道逆流症（GERD）醫療設備的現況正因微創胃腸病學、客觀逆流診斷和價值醫療的整合而改變。門診pH監測和電阻-pH聯合檢測的臨床意義日益凸顯，因為它們有助於區分酸性逆流、弱酸性逆流、非酸性逆流、功能性胃灼熱和反流過敏。高解析度食道測壓擴大用於評估抗逆流手術前的食道動力，並減少術後併發症，例如吞嚥困難。治療方法也不斷創新，內視鏡和腹腔鏡技術旨在改善下食道括約肌的屏障功能，同時最大限度地減少解剖損傷。醫院和門診手術中心正優先採用有助於縮短手術時間、可預測治療結果並降低併發症的醫療設備。另一項重大轉變是向實證醫療設備選擇模式的過渡，在這種模式下，治療策略的發展是基於逆流測試、食道裂孔疝氣的狀況、體重指數（BMI）、症狀表現以及對抑酸治療的反應。實施的成功取決於臨床醫生的經驗、跨學科協作以及標準化的患者選擇方案，這使得培訓系統日益重要。這些變化要求製造商和醫療保健提供者將醫療設備的研發與臨床指南、真實世界數據、保險報銷機制以及以患者為中心的治療結果相協調。

人工智慧（AI）的累積影響

人工智慧 (AI) 正逐步影響胃食道逆流症 (GERD)醫療設備的創新，包括診斷、治療計畫、工作流程最佳化和治療後監測。在逆流篩檢中，AI 驅動的分析可以識別逆流事件、對模式進行分類、減輕人工驗證的負擔，並加快對 pH 值、電阻及其與症狀相關性等數據的解讀。在食道動力評估中，機器學習技術可以提高對動力障礙的識別率，使臨床醫生能夠更一致地解讀複雜的高解析度測壓圖。 AI 還可以透過輔助影像分析、記錄和品管來增強內視鏡工作流程，尤其是在 GERD 與糜爛性食道炎和巴瑞特氏食道症等併發症後續觀察的情況下。對於醫療設備開發商而言，從真實臨床數據中獲得的 AI主導的洞察可以幫助進行患者細分、手術風險評估和結果追蹤。然而，AI 的累積影響取決於檢驗的演算法、透明的性能指標、與醫院系統的互通性、網路安全措施以及對醫療設備法規的遵守情況。短期內，最現實的機會不是取代臨床醫生，而是支持決策、提高測試可重複性、簡化報告流程，並實現更個人化的胃食道逆流症護理路徑。

關於胃食道逆流症醫療設備的關鍵區域見解

亞太地區正成為胃食道逆流（GERD）醫療器材的重要成長市場，這主要得益於都市化、飲食結構變化、肥胖趨勢以及醫療設備管道的改善，中國、印度、日本、韓國、澳洲和東南亞等地的診斷和治療病例均有所增加。雖然配備內視鏡和運動功能檢測設備的先進醫院網路對這些器械的接受度最高，但價格負擔和基礎設施差異仍然是新興市場面臨的障礙。在北美，門診逆流監測、高解析度測壓、腹腔鏡抗逆流手術和先進內視鏡檢查已高度融入臨床實踐，這得益於專科醫生的配備、完善的手術培訓以及保險公司對「醫療必要性證明」的重視。在拉丁美洲，私立醫療系統和主要城市醫院正在擴大這些器械的覆蓋範圍，其中巴西和墨西哥引領了這些手術的普及，但報銷制度的差異和診斷能力的不均衡限制了其更廣泛的應用。在歐洲，基於指南的胃食道逆流（GERD）管理、完善的內視鏡基礎設施以及對客觀的術前檢查的需求是其優勢所在，而國家醫療技術評估流程和成本效益要求則影響著內視鏡設備的普及應用。在中東，尤其是在海灣國家，透過對三級醫療機構、醫療旅遊中心和專科培訓的投資，內視鏡技術正取得進展；而非洲仍處於起步階段，內視鏡檢查、診斷基礎設施和專科醫師的可近性是影響設備普及應用的重要因素。在所有地區，推動內視鏡技術普及應用的最主要因素是客觀診斷、對微創治療的偏好以及治療僅靠長期藥物治療無法解決的難治性胃食道逆流的需求。

該集團在主要經濟區的主要見解

東南亞國協的胃食道逆流（GERD）醫療設備市場呈現多元化格局，新加坡、泰國、馬來西亞、印尼、越南和菲律賓等國的內視鏡檢查能力、私立醫院投資水平以及反流病診斷的可及性各不相同。部分國家對慢性逆流症狀的認知不斷提高、胃腸病學服務的擴展以及醫療旅遊的興起，推動了市場需求的成長。海灣合作理事會（GCC）國家的特點是醫療保健投資高、醫院基礎設施先進，以及對微創消化器官系統手術的需求不斷成長，而肥胖和代謝性疾病患病率的上升進一步提升了臨床對GERD治療的關注度。歐盟擁有成熟的監管和臨床體系，醫療設備的採用受到循證標準、合格評定要求、報銷管理以及在侵入性治療前遵循指南進行pH監測、電阻測試和測壓等檢查的限制。金磚國家蘊藏著巨大且多元化的商業機會。在中國和印度，專科醫生資源和手術數量都在不斷增加；在巴西和南非，大型私立醫院網路的需求日益成長；在俄羅斯，儘管採購流程複雜，但其既有的外科手術和內視鏡檢查能力仍得以維持。在七國集團（G7）國家，先進診斷技術的應用總體呈上升趨勢，醫生培訓網路健全，嚴重胃腸道疾病的治療涵蓋範圍廣，但成本控制和臨床效用驗證仍然是重大挑戰。北約成員國的市場與北美和歐洲市場高度重疊，這些地區的採購標準、醫院品管系統和監管要求支持胃食道逆流（GERD）醫療設備的系統性應用。在這些全部區域，醫療設備若能將專家技術、客觀的逆流檢測、保險報銷以及病患對持續微創治療的需求結合，則醫療器材的應用最為先進。

主要國家的發展趨勢正在影響對胃食道逆流（GERD）設備的需求。

美國仍然是胃食道逆流（GERD）治療設備應用最先進的國家之一，這得益於其廣泛的門診逆流檢測、高解析度測壓、內視鏡檢查以及在專業醫療中心開展的抗逆流手術，以及強調在進行侵入性治療前記錄客觀檢查觀察的報銷政策。在加拿大，設備應用正透過公立醫院系統和專科轉診途徑逐步推進，但各省的就診機會和手術等待時間存在差異。在墨西哥，GERD設備的使用正透過私立醫院和都市區專科醫療中心不斷擴展，而公共醫療部門的就診機會仍然有限。巴西擁有大規模的胃腸病學和減肥手術體系，為反流診斷和抗逆流治療提供支持，尤其是在主要大都市地區。在英國，實證治療方案備受重視，客觀的逆流檢測和內視鏡檢查已被納入難治性症狀的專科評估中。德國憑藉其強大的外科手術、內視鏡檢查和診斷基礎設施，支持食道測壓、pH監測和微創抗逆流療法的先進應用。法國、義大利和西班牙擁有完善的胃腸病學網路，其覆蓋範圍受公共醫療保險報銷政策和臨床指南遵循情況的影響。在俄羅斯，主要醫療中心已具備專業能力，但採購和區域可近性差異影響了醫療設備的可用性。在中國，內視鏡檢查能力、專科培訓和院內診斷正在迅速發展，為引入用於治療胃食道逆流（GERD）的醫療設備創造了廣泛的機會。在印度，私立綜合醫院和不斷擴展的都市區胃腸病學網路需求旺盛，但成本效益和農村地區的可及性仍然是主要限制因素。在日本，先進的內視鏡技術和完善的診斷標準已建立，支持對GERD患者進行嚴格的篩選和治療。在澳大利亞，高度專業化的醫療照護與系統化的轉診途徑相結合；而在韓國，內視鏡檢查的高利用率以及醫院引進技術的進步，正在支持先進的胃食道逆流症診斷和治療設備的廣泛使用。

為行業領導者提供的實用建議

產業領導者應優先考慮具有臨床差異化的胃食道逆流（GERD）設備，這些設備能夠提高診斷準確性、簡化工作流程，並支持對難治性患者進行微創治療。產品策略應與基於指南的臨床路徑保持一致，這些路徑要求在干預前進行客觀的反流測試、食道動力評估和嚴格的患者篩選。由於抗逆流設備手術的治療效果與醫生的經驗和病例選擇的合理性密切相關，製造商應投資於醫生培訓、模擬訓練、指導醫生培訓和標準化手術流程。證據累積應包括真實世界的治療結果、耐久性數據、患者報告的症狀改善情況、不利事件追蹤以及與標準內科和外科治療方法的療效比較。銷售團隊應針對每個國家和醫療機構最佳化報銷策略，強調減少復診次數、最佳化藥物使用、縮短復原時間和提高生活品質等帶來的健康經濟價值。數位化整合也至關重要。能夠與電子健康記錄整合、自動產生報告並支援人工智慧輔助解讀觀察的設備可以加速在高流量醫療機構中的應用。最後，領導者應認知到基礎設施的差異，並制定區域准入策略，提供可擴展的診斷平台、培訓夥伴關係以及適合成熟和新興醫療保健系統的服務模式。

調查方法

本執行摘要採用系統性的二手調查方法編寫，並專注於檢驗的臨床、監管和醫療保健系統證據。輸入資料包括同儕審查的胃腸病學文獻、國際公認的臨床指南、醫療設備法律規範、公共衛生資料集、醫院診療路徑文件以及已發表的關於反流診斷和反流預防干預措施的證據。分析重點在於門診pH監測、電阻pH測試、測壓法、內視鏡治療、腹腔鏡器械和植入式逆流預防技術等設備的相關性。研究整合了來自醫療保健基礎設施指標、疾病管理實踐、專科醫生資源、手術部署模式、報銷考慮因素以及內視鏡和運動功能測試可及性的區域、群體和國家特定見解。調查方法避免了未經證實的數值預測，因此不涉及市場規模、市場佔有率和預測。研究結果在多個證據類別中進行交叉驗證，以確保其對相關人員（包括醫療設備製造商、醫療保健提供者、採購團隊、投資者和政策觀察員）具有可檢驗。因此，本文提供了基於證據的見解，闡述了胃食道逆流症 (GERD)醫療設備的採用如何受到臨床需求、技術成熟度、監管期望和區域醫療保健系統的影響。

結論

用於治療胃食道逆流症 (GERD) 的醫療設備正從症狀評估的輔助角色轉向在精準診斷和標靶介入中發揮更具策略性的作用。最大的機會在於客觀的逆流測試、高解析度的運動功能評估、微創逆流預防手術以及能夠改善工作流程和觀察解讀的數位化工具。實施的成功仍取決於臨床證據、醫生培訓、與保險報銷系統的兼容性、監管合規性以及能否證明其對患者的永續益處。在成熟市場，基於指南的治療路徑和整合的專科護理推動了進展；而在新興市場，內視鏡技術的擴展、對私立醫療保健的投資以及對慢性反流病日益成長的認知正在促進需求成長。人工智慧 (AI) 在檢驗和管治得到有效維護的前提下，將透過提高診斷一致性、報告效率和患者分層帶來新的附加價值。擁有臨床可靠性、易用性、實證能力和區域准入策略的行業相關人員將最有利於支持不斷發展的胃食道逆流 (GERD) 診療體系。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：胃食道逆流症治療醫療設備市場：依產品類型分類

  • 內視鏡縫合器械
    • 相互競爭的縫合系統
    • 包縫系統
  • 磁性括約肌增強裝置
    • 第一代系統
    • 下一代系統
  • 射頻消融術裝置
    • 先進的導管系統
    • 標準導管系統
  • 手術經費申請設備
    • 傳統腹腔鏡系統
    • 機器人輔助腹腔鏡手術系統
  • 無需口腔切口的胃底折疊裝置
    • Esophyx Systems
    • 下一代基金申請系統

第8章：胃食道逆流症治療醫療設備市場：依手術類型分類

  • 診斷程序
  • 治療技術
    • 內視鏡手術
    • 手術治療
      • 腹腔鏡胃底折疊術
      • 電刺激療法
  • 監測程序
    • 短期住院監測
    • 長期攜帶式監測

第9章：治療胃食道逆流的醫療設備市場：依最終用戶分類

  • 門診手術中心
    • 獨立醫療機構
    • 醫院附設設施
  • 診所
    • 基層醫療診所
    • 專科診所
  • 醫院
    • 綜合醫院
    • 專業醫療中心
      • 胃腸病專科中心
      • 多專科醫療中心

第10章：治療胃食道逆流病醫療設備市場：依分銷管道分類

  • 離線
  • 線上
    • 電子商務平台
    • 製造商門戶

第11章：胃食道逆流症治療醫療設備市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第12章：胃食道逆流症治療醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第13章 治療胃食道逆流的醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第14章 競爭格局

  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第15章：公司簡介

  • Ambu AS
  • Apollo Endosurgery
  • Boston Scientific Corporation
  • C2 Therapeutics
  • ConMed Corporation
  • Diversatek Healthcare Inc
  • EndoGastric Solutions Inc
  • EndoStim Inc
  • Enterra Medical Inc
  • Erbe Elektromedizin GmbH
  • Fujifilm Holdings Corporation
  • Johnson & Johnson Services Inc
  • Koninklijke Philips NV
  • Laborie Medical Technologies
  • Mederi Therapeutics Inc
  • Medigus Ltd
  • Medtronic PLC
  • MICRO-TECH Nanjing Co Ltd
  • Olympus Corporation
  • Pentax Medical
  • ReShape Lifesciences Inc
  • Richard Wolf GmbH
  • Stryker Corporation
Product Code: MRR-925E8149CEF2

The Gastroesophageal Reflux Disease Devices Market is projected to grow by USD 2.08 billion at a CAGR of 8.81% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 1.15 billion
Estimated Year [2026] USD 1.22 billion
Forecast Year [2032] USD 2.08 billion
CAGR (%) 8.81%

GERD Devices Market Introduction

Gastroesophageal reflux disease (GERD) devices are increasingly central to diagnosis, symptom management, and interventional treatment as GERD remains one of the most common chronic gastrointestinal disorders worldwide. The category spans ambulatory pH and impedance monitoring systems, esophageal manometry platforms, endoscopic therapy devices, radiofrequency-based systems, implantable anti-reflux technologies, and laparoscopic surgical instruments used in fundoplication and sphincter augmentation procedures. Demand is supported by the clinical need to confirm reflux burden, identify non-erosive reflux disease, guide therapy-resistant cases, and reduce long-term dependence on pharmacologic treatment in appropriately selected patients. Healthcare systems are also emphasizing objective testing before invasive intervention, reinforcing the role of advanced diagnostic devices. At the same time, patient preference for minimally invasive procedures, shorter recovery times, and durable symptom control is reshaping adoption patterns. Regulatory scrutiny, reimbursement variability, physician training requirements, and evidence-generation standards continue to influence commercialization. The GERD devices landscape is therefore defined by a shift from symptom-based care toward precision diagnosis, patient stratification, and targeted procedural treatment.

Transformative Shifts in GERD Device Adoption

The GERD devices landscape is being transformed by the convergence of minimally invasive gastroenterology, objective reflux diagnostics, and value-based care. Ambulatory pH monitoring and combined impedance-pH testing are gaining clinical importance because they help distinguish acid reflux, weakly acidic reflux, non-acid reflux, functional heartburn, and reflux hypersensitivity. High-resolution manometry is increasingly used before anti-reflux procedures to assess esophageal motility and reduce postoperative complications such as dysphagia. Procedural innovation is also advancing, with endoscopic and laparoscopic technologies designed to improve the lower esophageal sphincter barrier while limiting anatomical disruption. Hospitals and ambulatory surgical centers are prioritizing devices that support faster procedures, predictable outcomes, and lower complication risk. Another major shift is the movement toward evidence-based device selection, where treatment decisions depend on reflux testing, hiatal hernia status, body mass index, symptom profile, and response to acid suppression therapy. Training ecosystems are becoming more important as successful adoption depends on operator experience, multidisciplinary collaboration, and standardized patient selection protocols. These shifts are pushing manufacturers and healthcare providers to align device development with clinical guidelines, real-world evidence, reimbursement pathways, and patient-centered outcomes.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is beginning to influence GERD device innovation across diagnostics, procedure planning, workflow optimization, and post-treatment monitoring. In reflux testing, AI-enabled analytics can support faster interpretation of pH, impedance, and symptom association data by identifying reflux episodes, classifying patterns, and reducing manual review burden. In esophageal motility assessment, machine learning approaches may improve recognition of motility disorders and help clinicians interpret complex high-resolution manometry patterns more consistently. AI can also strengthen endoscopic workflows by supporting image analysis, documentation, and quality control, particularly when GERD overlaps with complications such as erosive esophagitis or Barrett's esophagus surveillance. For device developers, AI-driven insights from real-world clinical data can support patient segmentation, procedural risk assessment, and outcome tracking. However, the cumulative impact of AI depends on validated algorithms, transparent performance metrics, interoperability with hospital systems, cybersecurity safeguards, and compliance with medical device regulations. The most practical near-term opportunity is not replacing clinicians but augmenting decision-making, improving test reproducibility, streamlining reporting, and enabling more personalized GERD care pathways.

Key Regional Insights for GERD Devices

Asia-Pacific is becoming an important growth environment for GERD devices as urbanization, dietary changes, obesity trends, and greater access to specialist gastroenterology increase diagnosis and treatment volumes across China, India, Japan, South Korea, Australia, and Southeast Asia. Adoption is strongest in advanced hospital networks with endoscopy and motility testing capabilities, while affordability and infrastructure gaps remain barriers in emerging markets. North America demonstrates high clinical integration of ambulatory reflux monitoring, high-resolution manometry, laparoscopic anti-reflux surgery, and advanced endoscopic evaluation, supported by specialist availability, established procedural training, and payer emphasis on documented medical necessity. Latin America shows expanding access through private healthcare systems and major urban hospitals, with Brazil and Mexico leading procedural adoption, although reimbursement fragmentation and uneven diagnostic capacity constrain broader penetration. Europe benefits from guideline-driven GERD management, strong endoscopy infrastructure, and demand for objective testing before intervention, with adoption influenced by national health technology assessment processes and cost-effectiveness requirements. The Middle East is advancing through investment in tertiary hospitals, medical tourism hubs, and specialist training, particularly in Gulf countries, while Africa remains at an earlier stage where endoscopy access, diagnostic infrastructure, and specialist workforce availability strongly determine device uptake. Across all regions, the strongest adoption drivers are objective diagnosis, minimally invasive treatment preference, and the need to manage refractory GERD beyond long-term medication alone.

Key Group Insights Across Strategic Economies

ASEAN presents a diverse GERD device environment, with Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines showing different levels of endoscopy capacity, private hospital investment, and access to reflux diagnostics. Demand is supported by rising awareness of chronic reflux symptoms, expanding gastroenterology services, and medical tourism in select countries. The GCC is characterized by high healthcare investment, advanced hospital infrastructure, and growing demand for minimally invasive gastrointestinal procedures, with obesity and metabolic disease prevalence reinforcing clinical attention to GERD management. The European Union has a mature regulatory and clinical ecosystem in which device adoption is shaped by evidence standards, conformity assessment requirements, reimbursement controls, and guideline-based use of pH monitoring, impedance testing, and manometry before invasive treatment. BRICS countries represent a large and heterogeneous opportunity, with China and India expanding specialist access and procedure volumes, Brazil and South Africa showing demand in major private hospital networks, and Russia maintaining established surgical and endoscopic capabilities despite procurement complexity. G7 countries generally demonstrate advanced diagnostic adoption, strong physician training networks, and broader access to high-acuity gastroenterology procedures, although cost containment and proof of clinical utility remain critical. NATO member markets overlap substantially with North America and Europe, where procurement standards, hospital quality systems, and regulatory expectations support structured adoption of GERD devices. Across these groups, device uptake is strongest where healthcare systems combine specialist expertise, objective reflux testing, procedural reimbursement, and patient demand for durable minimally invasive treatment options.

Key Country Insights Shaping GERD Device Demand

The United States remains one of the most advanced GERD device environments due to broad access to ambulatory reflux testing, high-resolution manometry, endoscopic services, and anti-reflux surgery in specialist centers, with reimbursement policies favoring objective documentation before invasive care. Canada shows adoption through publicly funded hospital systems and specialist referral pathways, although access may vary by province and procedure wait times. Mexico is expanding GERD device use through private hospitals and urban specialty centers, while public-sector access remains more constrained. Brazil has a sizable gastroenterology and bariatric surgery ecosystem that supports reflux diagnostics and anti-reflux interventions, particularly in major metropolitan areas. The United Kingdom emphasizes evidence-based pathways, with objective reflux testing and endoscopy integrated into specialist evaluation for refractory symptoms. Germany benefits from strong surgical, endoscopic, and diagnostic infrastructure, supporting advanced use of manometry, pH monitoring, and minimally invasive anti-reflux approaches. France, Italy, and Spain maintain well-developed gastroenterology networks, with adoption shaped by public reimbursement policies and clinical guideline adherence. Russia has established specialist capability in major centers, though procurement conditions and regional access differences affect device availability. China is rapidly expanding endoscopy capacity, specialist training, and hospital-based diagnostics, creating broader opportunities for GERD device integration. India shows strong demand in private multispecialty hospitals and growing urban gastroenterology networks, while affordability and rural access remain key constraints. Japan has sophisticated endoscopic practice and strong diagnostic standards, supporting careful patient selection for GERD interventions. Australia combines advanced specialist care with structured referral pathways, while South Korea's strong endoscopy utilization and hospital technology adoption support growing use of advanced GERD diagnostic and treatment devices.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically differentiated GERD devices that improve diagnostic accuracy, simplify workflow, and support minimally invasive care for patients with refractory symptoms. Product strategies should align with guideline-based pathways that require objective reflux testing, esophageal motility assessment, and careful patient selection before intervention. Manufacturers should invest in physician training, simulation, proctoring, and standardized procedural protocols because outcomes in anti-reflux device procedures are closely linked to operator experience and correct case selection. Evidence generation should include real-world outcomes, durability data, patient-reported symptom improvement, adverse event tracking, and comparative effectiveness against standard medical and surgical approaches. Commercial teams should localize reimbursement strategies by country and care setting, emphasizing health-economic value such as reduced repeat consultations, optimized medication use, shorter recovery time, and improved quality of life. Digital integration is also essential; devices that connect with electronic health records, automate reporting, and support AI-assisted interpretation can improve adoption in high-volume centers. Finally, leaders should build regional access strategies that recognize infrastructure differences, offering scalable diagnostic platforms, training partnerships, and service models suited to both mature and emerging healthcare systems.

Research Methodology

This executive summary is developed using a structured secondary research methodology focused on verified clinical, regulatory, and healthcare-system evidence. Inputs include peer-reviewed gastroenterology literature, internationally recognized clinical guidelines, regulatory frameworks for medical devices, public health datasets, hospital care pathway documentation, and published evidence on reflux diagnostics and anti-reflux interventions. The analysis emphasizes device relevance across ambulatory pH monitoring, impedance-pH testing, manometry, endoscopic therapy, laparoscopic instrumentation, and implantable anti-reflux technologies. Regional, group, and country insights are synthesized from healthcare infrastructure indicators, disease management practices, specialist availability, procedure adoption patterns, reimbursement considerations, and access to endoscopy and motility testing. The methodology avoids unsupported numerical projections and excludes market sizing, market share, and forecasting. Findings are triangulated across multiple evidence categories to ensure practical relevance for stakeholders including device manufacturers, healthcare providers, procurement teams, investors, and policy observers. The result is an evidence-led view of how GERD device adoption is shaped by clinical need, technology readiness, regulatory expectations, and regional healthcare capacity.

Conclusion

GERD devices are moving from a supporting role in symptom evaluation to a more strategic position in precision diagnosis and targeted intervention. The strongest opportunities are linked to objective reflux testing, high-resolution motility assessment, minimally invasive anti-reflux procedures, and digital tools that improve workflow and interpretation. Adoption will continue to depend on clinical evidence, physician training, reimbursement alignment, regulatory compliance, and the ability to demonstrate durable patient benefit. Mature markets are advancing through guideline-based pathways and integrated specialist care, while emerging markets are building demand through expanding endoscopy capacity, private healthcare investment, and rising awareness of chronic reflux disease. Artificial intelligence adds a new layer of value by improving diagnostic consistency, reporting efficiency, and patient stratification, provided that validation and governance remain robust. Industry participants that combine clinical credibility, usability, evidence generation, and region-specific access strategies will be best positioned to support the evolving GERD care continuum.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. New Revenue Opportunities
  • 3.5. Next-Generation Business Models
  • 3.6. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Gastroesophageal Reflux Disease Devices Market, by Product Type

  • 7.1. Introduction
  • 7.2. Endoscopic Suturing Devices
    • 7.2.1. Competitor Suturing Systems
    • 7.2.2. Overstitch Systems
  • 7.3. Magnetic Sphincter Augmentation Devices
    • 7.3.1. First Generation Systems
    • 7.3.2. Next Generation Systems
  • 7.4. Radiofrequency Ablation Devices
    • 7.4.1. Advanced Catheter Systems
    • 7.4.2. Standard Catheter Systems
  • 7.5. Surgical Fundoplication Devices
    • 7.5.1. Conventional Laparoscopic Systems
    • 7.5.2. Robotic Assisted Laparoscopic Systems
  • 7.6. Transoral Incisionless Fundoplication Devices
    • 7.6.1. Esophyx Systems
    • 7.6.2. Next Generation Fundoplication Systems

8. Gastroesophageal Reflux Disease Devices Market, by Procedure Type

  • 8.1. Introduction
  • 8.2. Diagnostic Procedures
  • 8.3. Therapeutic Procedures
    • 8.3.1. Endoscopic Procedures
    • 8.3.2. Surgical Procedures
      • 8.3.2.1. Laparoscopic Fundoplication Procedures
      • 8.3.2.2. Electrical Stimulation Procedures
  • 8.4. Monitoring Procedures
    • 8.4.1. Short-Term In-Hospital Monitoring
    • 8.4.2. Long-Term Ambulatory Monitoring

9. Gastroesophageal Reflux Disease Devices Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
    • 9.2.1. Freestanding Centers
    • 9.2.2. Hospital Affiliated Centers
  • 9.3. Clinics
    • 9.3.1. Primary Care Clinics
    • 9.3.2. Specialty Clinics
  • 9.4. Hospitals
    • 9.4.1. General Hospitals
    • 9.4.2. Specialty Centers
      • 9.4.2.1. Gastroenterology Specialty Centers
      • 9.4.2.2. Multispecialty Centers

10. Gastroesophageal Reflux Disease Devices Market, by Distribution Channel

  • 10.1. Introduction
  • 10.2. Offline
  • 10.3. Online
    • 10.3.1. E Commerce Platforms
    • 10.3.2. Manufacturer Portals

11. Gastroesophageal Reflux Disease Devices Market, by Region

  • 11.1. Asia-Pacific
  • 11.2. North America
  • 11.3. Latin America
  • 11.4. Europe
  • 11.5. Middle East
  • 11.6. Africa

12. Gastroesophageal Reflux Disease Devices Market, by Group

  • 12.1. ASEAN
  • 12.2. GCC
  • 12.3. European Union
  • 12.4. BRICS
  • 12.5. G7
  • 12.6. NATO

13. Gastroesophageal Reflux Disease Devices Market, by Country

  • 13.1. United States
  • 13.2. Canada
  • 13.3. Mexico
  • 13.4. Brazil
  • 13.5. United Kingdom
  • 13.6. Germany
  • 13.7. France
  • 13.8. Russia
  • 13.9. Italy
  • 13.10. Spain
  • 13.11. China
  • 13.12. India
  • 13.13. Japan
  • 13.14. Australia
  • 13.15. South Korea

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2025
  • 14.2. FPNV Positioning Matrix, 2025
  • 14.3. Market Concentration Analysis, 2025
    • 14.3.1. Concentration Ratio (CR)
    • 14.3.2. Herfindahl Hirschman Index (HHI)
  • 14.4. Recent Developments & Impact Analysis, 2025
  • 14.5. Product Portfolio Analysis, 2025
  • 14.6. Benchmarking Analysis, 2025

15. Company Profiles

  • 15.1. Ambu AS
  • 15.2. Apollo Endosurgery
  • 15.3. Boston Scientific Corporation
  • 15.4. C2 Therapeutics
  • 15.5. ConMed Corporation
  • 15.6. Diversatek Healthcare Inc
  • 15.7. EndoGastric Solutions Inc
  • 15.8. EndoStim Inc
  • 15.9. Enterra Medical Inc
  • 15.10. Erbe Elektromedizin GmbH
  • 15.11. Fujifilm Holdings Corporation
  • 15.12. Johnson & Johnson Services Inc
  • 15.13. Koninklijke Philips NV
  • 15.14. Laborie Medical Technologies
  • 15.15. Mederi Therapeutics Inc
  • 15.16. Medigus Ltd
  • 15.17. Medtronic PLC
  • 15.18. MICRO-TECH Nanjing Co Ltd
  • 15.19. Olympus Corporation
  • 15.20. Pentax Medical
  • 15.21. ReShape Lifesciences Inc
  • 15.22. Richard Wolf GmbH
  • 15.23. Stryker Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 7. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 21. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025

LIST OF TABLES

  • TABLE 1. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SEGMENTATION & COVERAGE
  • TABLE 2. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL ENDOSCOPIC SUTURING DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL ENDOSCOPIC SUTURING DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL ENDOSCOPIC SUTURING DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL COMPETITOR SUTURING SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL COMPETITOR SUTURING SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL COMPETITOR SUTURING SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL OVERSTITCH SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL OVERSTITCH SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL OVERSTITCH SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL MAGNETIC SPHINCTER AUGMENTATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL MAGNETIC SPHINCTER AUGMENTATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL MAGNETIC SPHINCTER AUGMENTATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL FIRST GENERATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL FIRST GENERATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL FIRST GENERATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL NEXT GENERATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL NEXT GENERATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL NEXT GENERATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL RADIOFREQUENCY ABLATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL ADVANCED CATHETER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL ADVANCED CATHETER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL ADVANCED CATHETER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL STANDARD CATHETER SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL STANDARD CATHETER SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL STANDARD CATHETER SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL SURGICAL FUNDOPLICATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL SURGICAL FUNDOPLICATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL SURGICAL FUNDOPLICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONVENTIONAL LAPAROSCOPIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONVENTIONAL LAPAROSCOPIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL CONVENTIONAL LAPAROSCOPIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL ROBOTIC ASSISTED LAPAROSCOPIC SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL ESOPHYX SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL ESOPHYX SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL ESOPHYX SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL NEXT GENERATION FUNDOPLICATION SYSTEMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL NEXT GENERATION FUNDOPLICATION SYSTEMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL NEXT GENERATION FUNDOPLICATION SYSTEMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL DIAGNOSTIC PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL THERAPEUTIC PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL THERAPEUTIC PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL THERAPEUTIC PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL ENDOSCOPIC PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL ENDOSCOPIC PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOSCOPIC PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LAPAROSCOPIC FUNDOPLICATION PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LAPAROSCOPIC FUNDOPLICATION PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL LAPAROSCOPIC FUNDOPLICATION PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL ELECTRICAL STIMULATION PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL ELECTRICAL STIMULATION PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL ELECTRICAL STIMULATION PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MONITORING PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MONITORING PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MONITORING PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL SHORT-TERM IN-HOSPITAL MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL SHORT-TERM IN-HOSPITAL MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL SHORT-TERM IN-HOSPITAL MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL LONG-TERM AMBULATORY MONITORING MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL LONG-TERM AMBULATORY MONITORING MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL LONG-TERM AMBULATORY MONITORING MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL FREESTANDING CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL HOSPITAL AFFILIATED CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL HOSPITAL AFFILIATED CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL HOSPITAL AFFILIATED CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PRIMARY CARE CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PRIMARY CARE CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PRIMARY CARE CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL SPECIALTY CLINICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL SPECIALTY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL GASTROENTEROLOGY SPECIALTY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL GASTROENTEROLOGY SPECIALTY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL GASTROENTEROLOGY SPECIALTY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL MULTISPECIALTY CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL MULTISPECIALTY CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL MULTISPECIALTY CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL E COMMERCE PLATFORMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL MANUFACTURER PORTALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL MANUFACTURER PORTALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL MANUFACTURER PORTALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 177. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 178. LATIN AMERICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 195. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 196. EUROPE GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 210. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 211. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 212. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 213. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 214. MIDDLE EAST GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 225. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 226. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 227. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 228. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 229. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 230. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 231. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 232. AFRICA GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 242. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 243. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 244. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 245. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 246. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 247. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 248. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 249. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 250. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 251. ASEAN GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 252. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 254. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 255. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 256. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 257. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 258. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 259. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 261. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 262. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 263. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 264. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 265. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 266. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 267. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 268. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 269. GCC GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 274. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 275. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 276. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 278. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 279. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 280. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 281. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 282. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, 2018-2032 (USD MILLION)
  • TABLE 283. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY CLINICS, 2018-2032 (USD MILLION)
  • TABLE 284. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 285. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SPECIALTY CENTERS, 2018-2032 (USD MILLION)
  • TABLE 286. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 287. EUROPEAN UNION GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 290. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY ENDOSCOPIC SUTURING DEVICES, 2018-2032 (USD MILLION)
  • TABLE 291. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MAGNETIC SPHINCTER AUGMENTATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 292. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY RADIOFREQUENCY ABLATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 293. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 294. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY TRANSORAL INCISIONLESS FUNDOPLICATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 295. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY THERAPEUTIC PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 297. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 298. BRICS GASTROESOPHAGEAL REFLUX DISEASE DEVICES MARKET SIZE, BY MONITORING PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 299. BRICS GAST